'Hunger hormone' could help chemo patients: study
February 10, 2012 — NEW YORK (Reuters Health) - A synthetic version of the "hunger hormone" ghrelin might help limit the loss of appetite that can come with cancer chemotherapy, a small study from Japan suggests.
Most women with cancer want a role in decisions
February 9, 2012 — NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.
U.S. FDA sets draft rules for biotech drug copies
February 9, 2012 —
Select news items provided by Reuters Health